Agnes Yuet Ying Lee

Summary

Affiliation: McMaster University
Country: Canada

Publications

  1. ncbi Anti-thrombotic therapy in cancer patients
    Agnes Y Y Lee
    Department of Medicine, McGill University, Hamilton, ON L8V 1C3, Canada
    Expert Opin Pharmacother 4:2213-20. 2003
  2. ncbi Bilateral vs. ipsilateral venography as the primary efficacy outcome measure in thromboprophylaxis clinical trials: a systematic review
    A Y Y Lee
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    J Thromb Haemost 2:1752-9. 2004
  3. ncbi Venous thromboembolism and cancer: prevention and therapy
    Agnes Y Y Lee
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Vnitr Lek 52:127-8, 130-1. 2006
  4. ncbi Thrombosis and cancer: the role of screening for occult cancer and recognizing the underlying biological mechanisms
    Agnes Y Y Lee
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Hematology Am Soc Hematol Educ Program . 2006
  5. pmc Cancer-associated thrombosis: prevention and treatment
    K M J Brose
    Queen s University, Kingston, Ontario
    Curr Oncol 15:S58-67. 2008
  6. ncbi Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer
    Agnes Y Y Lee
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    J Clin Oncol 24:1404-8. 2006
  7. ncbi The role of low-molecular-weight heparins in treating thrombosis
    Agnes Y Y Lee
    McMaster University, Hamilton Health Sciences, Henderson General Hospital, Ontario, Canada
    J Support Oncol 4:123-4. 2006
  8. ncbi Cancer and thromboembolic disease: pathogenic mechanisms
    Agnes Y Lee
    Hamilton Health Sciences, Henderson Site, Ont, Canada L8V 1C3
    Cancer Treat Rev 28:137-40. 2002
  9. ncbi Cancer and venous thromboembolism: prevention, treatment and survival
    Agnes Yuet Ying Lee
    Department of Medicine, McMaster University, Hamilton, ON, Canada
    J Thromb Thrombolysis 25:33-6. 2008
  10. ncbi Prevention of deep vein thrombosis in cancer patients
    Agnes Y Y Lee
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Semin Thromb Hemost 33:699-706. 2007

Detail Information

Publications21

  1. ncbi Anti-thrombotic therapy in cancer patients
    Agnes Y Y Lee
    Department of Medicine, McGill University, Hamilton, ON L8V 1C3, Canada
    Expert Opin Pharmacother 4:2213-20. 2003
    ..The preliminary observations that LMWHs are associated with reduction in cancer mortality make these agents an attractive therapeutic option in oncology patients...
  2. ncbi Bilateral vs. ipsilateral venography as the primary efficacy outcome measure in thromboprophylaxis clinical trials: a systematic review
    A Y Y Lee
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    J Thromb Haemost 2:1752-9. 2004
    ....
  3. ncbi Venous thromboembolism and cancer: prevention and therapy
    Agnes Y Y Lee
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Vnitr Lek 52:127-8, 130-1. 2006
    ..This review will provide an update on the primary prevention and treatment of VTE, as well as prophylaxis for central venous catheters, in patients with malignancy...
  4. ncbi Thrombosis and cancer: the role of screening for occult cancer and recognizing the underlying biological mechanisms
    Agnes Y Y Lee
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Hematology Am Soc Hematol Educ Program . 2006
    ....
  5. pmc Cancer-associated thrombosis: prevention and treatment
    K M J Brose
    Queen s University, Kingston, Ontario
    Curr Oncol 15:S58-67. 2008
    ..Other therapeutic options, such as inferior caval filters, are poorly studied and remain controversial. A summary of the most recent evidence on the prevention and treatment of venous thromboembolism in cancer patients is presented here...
  6. ncbi Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer
    Agnes Y Y Lee
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    J Clin Oncol 24:1404-8. 2006
    ..We performed a prospective study to examine the incidence, risk factors, and long-term complications of symptomatic catheter-related thrombosis (CRT) in adults with cancer...
  7. ncbi The role of low-molecular-weight heparins in treating thrombosis
    Agnes Y Y Lee
    McMaster University, Hamilton Health Sciences, Henderson General Hospital, Ontario, Canada
    J Support Oncol 4:123-4. 2006
  8. ncbi Cancer and thromboembolic disease: pathogenic mechanisms
    Agnes Y Lee
    Hamilton Health Sciences, Henderson Site, Ont, Canada L8V 1C3
    Cancer Treat Rev 28:137-40. 2002
    ..Tumour-induced coagulation is intrinsically involved with tumour growth, angiogenesis and metastasis...
  9. ncbi Cancer and venous thromboembolism: prevention, treatment and survival
    Agnes Yuet Ying Lee
    Department of Medicine, McMaster University, Hamilton, ON, Canada
    J Thromb Thrombolysis 25:33-6. 2008
    ..This brief review will provide an update on the primary prevention and treatment of VTE and discuss the evidence for the survival advantage associated with LMWH use in patients with malignancy...
  10. ncbi Prevention of deep vein thrombosis in cancer patients
    Agnes Y Y Lee
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Semin Thromb Hemost 33:699-706. 2007
    ..This review will provide a summary of the evidence on the primary prevention of VTE in patients with cancer...
  11. ncbi The effects of low molecular weight heparins on venous thromboembolism and survival in patients with cancer
    Agnes Y Y Lee
    Department of Medicine, McMaster University Hamilton, Ontario, Canada
    Thromb Res 120:S121-7. 2007
    ..This review will briefly summarize the data on the treatment of VTE in cancer patients with LMWH and discuss the experimental and clinical data on its possible anticancer effects...
  12. ncbi Treatment of venous thromboembolism in cancer patients
    Agnes Lee
    Department of Medicine, McMaster University, Hamilton Health Sciences Henderson Hospital, Hamilton, ON, L8V 1C3 Canada
    Cancer Control 12:17-21. 2005
  13. ncbi Elevated levels of D-dimer and fragment 1+2 upon central venous catheter insertion and factor V Leiden predict subclavian vein thrombosis
    Agnes Lee
    Associate Professor, Medicine, McMaster University Hamilton Health Sciences Henderson General Hospital
    Haematologica 90:437. 2005
    ..Further studies are required to confirm these findings and to see if similar results are observed in patients with other malignancies...
  14. ncbi Management of thrombosis in cancer: primary prevention and secondary prophylaxis
    Agnes Y Y Lee
    Department of Medicine, McMaster University, Hamilton, ON, Canada
    Br J Haematol 128:291-302. 2005
    ..A brief discussion of the potential application of novel anticoagulants in these clinical settings is also included...
  15. ncbi Venous thromboembolism and cancer: risks and outcomes
    Agnes Y Y Lee
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Circulation 107:I17-21. 2003
    ..The antineoplastic effects of anticoagulants are being actively investigated with promising preliminary results...
  16. ncbi The role of low-molecular-weight heparins in the prevention and treatment of venous thromboembolism in cancer patients
    Agnes Y Y Lee
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Curr Opin Pulm Med 9:351-5. 2003
    ..Although the management of cancer patients with venous thromboembolism remains challenging, low-molecular-weight heparins have simplified and improved the prevention and treatment of venous thromboembolism in these high-risk patients...
  17. ncbi Treatment and secondary prophylaxis of VTE in the cancer patient: current status
    Agnes Y Y Lee
    Hamilton Civic Hospitals Research Center, Hamilton, Canada
    Pathophysiol Haemost Thromb 33:42-3. 2003
  18. ncbi Recombinant nematode anticoagulant protein c2 and other inhibitors targeting blood coagulation factor VIIa/tissue factor
    A Y Y Lee
    Department of Medicine, McMaster University, Hamilton, ON, Canada
    J Intern Med 254:313-21. 2003
    ....
  19. ncbi Epidemiology and management of venous thromboembolism in patients with cancer
    Agnes Y Y Lee
    Department of Medicine, McMaster University, Hamilton, ON, Canada
    Thromb Res 110:167-72. 2003
    ..Whether LMWH is capable of modifying tumour biology remains unanswered. Further research is needed to address the many clinical questions in the management of thrombosis in patients with cancer...
  20. ncbi Screening for occult cancer in patients with idiopathic venous thromboembolism: no
    A Y Y Lee
    McMaster University, Hamilton Health Sciences Henderson General Hospital, 711 Concession Street, Hamilton, ON, Canada
    J Thromb Haemost 1:2273-4. 2003
  21. doi VTE in patients with cancer--diagnosis, prevention, and treatment
    Agnes Lee
    Department of Medicine, McMaster University, and Hamilton Health Sciences Henderson Hospital, 711 Concession Street, Hamilton, ON Canada L8V 1C3
    Thromb Res 123:S50-4. 2008
    ..This review will focus on the current standards of practice for the diagnosis, prevention and treatment of VTE in patients with cancer...